Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
BMC Cancer|June 1, 2025
Synergistic effects of PD-1 antibody and chemotherapy followed by surgery-centric local treatment in patients with limited-metastatic gastric or gastroesophageal adenocarcinoma (ROSETTE trial): an open-label, single-center, randomized phase 2 trialYing Ying Wu, Lian Chen Lee, Hong Zeng, et al.International Journal of Cancer|October 25, 2013
HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: a prospective cohort observationMiao-Zhen Qiu, Qian Li, Zhi-Qiang Wang, et al.Frontiers in Oncology|December 13, 2021
The Impact of Mismatch Repair Status on Prognosis of Patients With Gastric Cancer: A Multicenter AnalysisWen-Long Guan, Yue Ma, Yue-Hong Cui, et al.Journal of Molecular Medicine (Berlin, Germany)|July 10, 2012
Exon 47 skipping of fibrillin-1 leads preferentially to cardiovascular defects in patients with thoracic aortic aneurysms and dissectionsWen-Jing Wang, Peili Han, Jun Zheng, et al.Clinical and Translational Science|November 29, 2024
Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring FGFR2 gene amplificationJiajia Yuan, Lin Shen, Tian Shu Liu, et al.Oncotarget|September 9, 2017
Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinomaEr-Bao Chen, Shao-Lai Zhou, Xu-Guang Pang, et al.European Heart Journal. Cardiovascular Imaging|December 10, 2024
Non-invasive myocardial work in severe aortic regurgitation: implications for post-operative left ventricular dysfunctionYu-Ting Tan, Yao-Ling Wang, Abudukadier Abulipizi, et al.Chinese Journal of Cancer|June 27, 2015
Right-sided colon cancer and left-sided colorectal cancers respond differently to cetuximabFeng Wang, Long Bai, Tian-Shu Liu, et al.American Journal of Cancer Research|October 12, 2020
Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm studyFeng Wang, Tian-Shu Liu, Xiang-Lin Yuan, et al.Chinese Journal of Cancer|January 16, 2016
Expert consensus on maintenance treatment for metastatic colorectal cancer in ChinaRui-Hua Xu, Lin Shen, Jin Li, et al.Pageof 7